0H22 vs 7AT: Side-by-Side Comparison
Compare Bioinvent International AB (0H22) and Attendo AB (publ) (7AT) side by side: valuation, financials, growth and model signals on Bullrun.
| Metric | 0H22 | 7AT |
|---|---|---|
| Company | Bioinvent International AB | Attendo AB (publ) |
| Country / Exchange | Sweden · LSE | Sweden · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Medical Care Facilities |
| Market cap | — | EUR 1.57B |
| P/E ratio | — | 20.8 |
| Dividend yield | — | 1.53% |
| Valuation model | — | 9.2% overvalued |
| Revenue (latest FY) | — | SEK 18.98B |
| Revenue growth YoY | — | +9.8% |
| Net income | — | SEK 450.00M |
| Gross margin | — | — |
| Diluted EPS | — | 2.85 |